New Weight-Loss drug shows promise in early trial
NCT ID NCT06230523
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 study tested a new drug called eloralintide (LY3841136) for weight management in 263 adults with obesity or overweight. Participants received either the drug or a placebo for about 64 weeks. The main goal was to see how much weight they lost after 48 weeks. Results will help determine if larger studies are warranted.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Eloralintide (LY3841136)
What this could lead to
If successful, this could lead to a new medication for weight management in people with obesity or overweight.
What could go wrong
This is an early phase 2 trial with only 263 participants. The drug may not prove effective or safe in larger studies, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan, 48098, United States
-
CTI Clinical Research Center
Cincinnati, Ohio, 45212, United States
-
Central Washington Health Services Association d/b/a Confluence Health
Wenatchee, Washington, 98801, United States
-
Charter Research - Lady Lake
The Villages, Florida, 32162, United States
-
Charter Research - Winter Park
Orlando, Florida, 32803, United States
-
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas, 66606, United States
-
Dent Neurologic Institute
Amherst, New York, 14226, United States
-
Diablo Clinical Research, Inc.
Walnut Creek, California, 94598, United States
-
Endeavor Clinical Trials
San Antonio, Texas, 78240, United States
-
FutureSearch Trials of Dallas
Dallas, Texas, 75251, United States
-
Great Lakes Clinical Trials - Andersonville
Chicago, Illinois, 60640, United States
-
Great Lakes Clinical Trials - Ravenswood
Chicago, Illinois, 60640, United States
-
Headlands Research - Detroit
Southfield, Michigan, 48034, United States
-
Headlands Research - Scottsdale
Scottsdale, Arizona, 85260, United States
-
IMA Clinical Research Austin
Austin, Texas, 78745, United States
-
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa, 50265, United States
-
Knownwell
Needham, Massachusetts, 02492, United States
-
L-MARC Research Center
Louisville, Kentucky, 40213, United States
-
Las Vegas Medical Research
Las Vegas, Nevada, 89128, United States
-
Lucas Research, Inc.
New Bern, North Carolina, 28562, United States
-
Lucida Clinical Trials
New Bedford, Massachusetts, 02740, United States
-
Medical Research Partners
Ammon, Idaho, 83406, United States
-
Medication Management
Greensboro, North Carolina, 27405, United States
-
Monroe Biomedical Research
Monroe, North Carolina, 28112, United States
-
NorCal Medical Research, Inc
Greenbrae, California, 94904, United States
-
North Suffolk Neurology
Port Jefferson Station, New York, 11776, United States
-
NorthShore University Health System
Skokie, Illinois, 60077, United States
-
Northeast Research Institute (NERI)
Fleming Island, Florida, 32003, United States
-
Pacific Diabetes & Endocrine Center
Honolulu, Hawaii, 96817, United States
-
Peninsula Research Associates
Rolling Hills Estates, California, 90274, United States
-
PlanIt Research, PLLC
Houston, Texas, 77079, United States
-
Quality Medical Research
Nashville, Tennessee, 37211, United States
-
Rochester Clinical Research, LLC
Rochester, New York, 14609, United States
-
Spectrum Medical, Inc.
Danville, Virginia, 24541, United States
-
StudyMetrix Research
City of Saint Peters, Missouri, 63303, United States
-
Suncoast Clinical Research, Inc.
New Port Richey, Florida, 34652, United States
-
Tekton Research - Fredericksburg Road
San Antonio, Texas, 78229, United States
-
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa
Chandler, Arizona, 85225, United States
-
The Institute for Liver Health II dba Arizona Liver Health-Tucson
Tucson, Arizona, 85712, United States
-
Tribe Clinical Research, LLC
Greenville, South Carolina, 29607, United States
-
Velocity Clinical Research, Dallas
Dallas, Texas, 75230, United States
-
Velocity Clinical Research, Huntington Park
Huntington Park, California, 90255, United States
-
Velocity Clinical Research, Syracuse
East Syracuse, New York, 13057, United States